The Hormones That Govern Bile
ABSURD Health Institute · Volume Two · Research Essay 21
Research series: 03 · Hepatobiliary, cholesterol and endocrine physiology
Abstract
Bile physiology and endocrine physiology influence each other, but claims that impaired bile directly causes generalized hormone deficiency go beyond current evidence. This paper maps known feedback between bile-acid synthesis, estrogen-related cholestasis, progesterone effects on motility, thyroid status and metabolic signaling. The aim is to identify precise directions of causality rather than invoke a single unexplained liver–hormone blockage.
Hormonal command of the enterohepatic system
Bile physiology is regulated by a coordinated endocrine network, so impaired signaling—not merely insufficient dietary fat—could explain some complex metabolic presentations.
Bile acids are synthesized from cholesterol; steroid hormones also derive from cholesterol, but they do not require dietary animal fat to arrive as a special intact substrate. The liver regulates steroid metabolism and excretion, while estrogen-related states can alter hepatobiliary transport and gallstone risk. Thyroid function affects lipid metabolism and gastrointestinal physiology. FXR/FGF19 feedback coordinates bile-acid synthesis, while intestinal bile acids help absorb fat-soluble nutrients. These pathways intersect but operate through distinct enzymes and control loops.
The strongest hypothesis concerns people with measurable hepatobiliary dysfunction in whom endocrine signs coexist. Associations could reflect altered clearance of hormone metabolites, intestinal nutrient absorption, hepatic inflammation, or third factors such as obesity. Correct analysis requires distinguishing plasma hormone concentration, receptor activity, hormone production and metabolic elimination. A low measured hormone is not evidence of failure to digest dietary fat.
Separating cholesterol from endocrine and bile signaling
The liver and endocrine glands share cholesterol-related chemistry but use it differently. Cholesterol is the precursor of steroid hormones through enzymatic pathways that operate in endocrine tissues, while bile-acid synthesis converts cholesterol into amphipathic compounds used for fat handling and signaling. Both processes are regulated, and the liver can clear hormones through conjugation and excretion. Thus a patient may have sufficient endogenous cholesterol for hormone synthesis despite consuming no cholesterol, or may have significant dyslipidemia while producing normal sex steroids. This distinction defeats simplistic analogies equating low dietary animal fat with hormone starvation.
Bile physiology participates in endocrine feedback loops rather than functioning under the command of a single hormone. Intestinal FXR activation promotes FGF19 signaling in humans, which can regulate hepatic bile-acid synthesis; feeding and intestinal transit shape the timing of this response. Other hormones influence gallbladder contraction, appetite, insulin sensitivity and gastrointestinal motility. This feedback architecture allows a local intestinal event to influence the liver without requiring that the liver simply receive more or less dietary fat.
A measurable prediction is that a disrupted timing relationship between bile-acid exposure and endocrine feedback could coexist with nearly normal total bile-acid concentration. To establish this, investigators would need repeated samples anchored to meals and circadian phase, not one fasting measurement. Cross-sectional associations between FGF19 and metabolic disorders may reflect feedback compensation rather than initiating hormone deficiency. The direction of causation is the central uncertainty.
FGF19 feedback, FXR activation, hepatic bile-acid synthesis and gallbladder motility form different layers of regulation. Thyroid function, estrogen exposure, diabetes, pregnancy and medications can affect the system, but a hormone that influences bile transport need not be itself made from ingested fat. Steroid hormones depend on cholesterol synthesis and trafficking, while essential fatty-acid status and fat-soluble vitamin absorption present separate nutritional questions. The new thesis should replace the vague assertion that “no fat means no hormones” with specific, biologically tractable pathways.
The informative meal-response experiment
An experimental protocol might compare standardized meal responses among participants with normal gallbladder function, post-cholecystectomy physiology and well-characterized intestinal bile-acid malabsorption. Outcomes would include symptom timing, validated bile-acid species, related hormones and selected lipid measures, with treatments and liver disease accounted for. The objective is not to label all hormonal imbalance as biliary failure, but to determine which abnormal feedback signatures have consequences that can be measured independently.
Feedback is a dynamic function. The liver does not simply synthesize a fixed amount of bile acids on demand. Hepatic and intestinal receptor systems respond to circulating and luminal signals and help regulate synthesis, pool composition and transport. A person could theoretically have a normal baseline marker but an altered postprandial response. Demonstrating such a phenotype requires repeated sampling under standardized conditions, because normal physiological oscillations are substantial.
A clinical example in principle. Consider two people with similar fasting bile-acid concentrations but different responses after a standardized meal. One shows an appropriately timed endocrine feedback signal, while the other's signal is delayed. If the second also has symptoms, the delay could be relevant—but it could equally result from slower gastric emptying, altered intestinal transit or a drug exposure. Measuring those variables is necessary before assigning causation to the endocrine feedback loop.
The hypothesis's payoff. The most interesting outcome is a validated dynamic test that identifies a subgroup not visible through conventional static measurements and predicts meaningful health consequences. That would justify studying the pathway as a modifiable target. Without replication and outcomes, unusual hormone curves may be physiologically interesting without being pathological. The clinical aim should be more accurate characterization, not automatic treatment of every variation from the average.
Study the response of FGF19, C4 and bile-acid species to standardized meals across endocrine states while accounting for medications and hepatic disease. Pair these measures with validated outcomes such as fat-soluble vitamin status or diagnosed cholestasis. The proposed endocrine link gains substance only when the intervening biochemical steps and expected direction of change can be demonstrated.
A clinically useful analysis should specify whether the hypothesized abnormality concerns hormone production, receptor signaling, tissue conversion, transport or elimination. Measurements that cannot distinguish these possibilities should not be presented as definitive. Pregnancy-associated cholestatic syndromes and thyroid-related changes in lipid metabolism offer concrete starting points, but cannot establish a universal nutrition–psychosis causal chain.
The misleading shortcut from animal fat to all hormones
A common claim in nutritional debate is that a person who eats too little animal fat cannot make hormones, and that impaired bile processing therefore produces almost any endocrine or psychiatric symptom. That argument skips essential steps. Human tissues synthesize cholesterol, steroidogenesis depends on enzyme and endocrine regulation, and different hormones are constructed from different molecular precursors. Inadequate energy, malnutrition, essential fatty-acid deficiency and poor absorption of vitamins can certainly have endocrine consequences, but those are not synonyms for deficient bile secretion. The Institute's more valuable hypothesis concerns a feedback loop: endocrine conditions alter bile-acid synthesis or transport; altered bile-acid patterns affect metabolic signaling; that changed physiology feeds back upon the endocrine milieu. It requires measurable intermediate variables and can have several directions. For example, a thyroid disorder might be the primary cause of altered cholesterol and gallbladder behavior rather than the consequence of it. The paper can make a formidable case for endocrine–biliary coupling without collapsing the entire field of hormone physiology into dietary fat intake.
One hormone does not explain every symptom
Endocrine feedback generates an important distinction between an abnormal baseline and an abnormal response to stimulation. If the system's output is measured only once, a delayed or exaggerated response can escape detection. But the opposite error is possible: treating an unusual curve as disease when it falls within ordinary biological variation. Standardized meal conditions, diurnal timing and repeated measurements are therefore central to any test of bile-mediated endocrine signaling. A useful cohort would compare the same feedback loop in people with a defined bile-acid disorder and in appropriately matched controls, while separately measuring gastrointestinal transit, liver function and medication exposure. If the feedback difference predicts an adverse outcome beyond these variables, the pathway becomes more clinically compelling. If it does not, the signature may be a harmless physiological variation. The hypothesis should lead to dynamic and discriminating tests rather than generalized diagnosis of hormone imbalance.
The idea that vegan diets inherently prevent steroid hormone synthesis is inaccurate: humans can synthesize cholesterol and steroid hormones without consuming cholesterol. A vegan diet can still create nutrient-deficiency risks if poorly planned, while animal-fat excess can raise cardiovascular risk in some dietary contexts. Seed oils do not become an undifferentiated toxic class merely because they contain polyunsaturated fats; oxidation, food processing, energy balance and fatty-acid substitution matter.
This paper should make the hormone–bile axis comprehensible through diagrams of directionality and compartments. It can legitimately argue against dismissing liver and intestinal disease in endocrine assessment, without claiming that supplementation with saturated fats treats psychiatric illness or corrects all hormone disorders.
Sources and research leads
Editorial status: Third-pass conceptual research manuscript. The argument has been individually strengthened and shared boilerplate removed. Original reference leads were retained; a complete independent source-by-source scholarly verification has not been performed. No new clinical trial data are presented.